Imaging in the era of molecular oncology
View/ Open
Author
Weissleder, Ralph
Pittet, Mikael J.
Published Version
https://doi.org/10.1038/nature06917Metadata
Show full item recordCitation
Weissleder, Ralph, and Mikael J. Pittet. 2008. “Imaging in the Era of Molecular Oncology.” Nature 452 (7187): 580–89. https://doi.org/10.1038/nature06917.Abstract
New technologies for imaging molecules, particularly optical technologies, are increasingly being used to understand the complexity, diversity and in vivo behaviour of cancers. 'Omic' approaches are providing comprehensive 'snapshots' of biological indicators, or biomarkers, of cancer, but imaging can take this information a step further, showing the activity of these markers in vivo and how their location changes over time. Advances in experimental and clinical imaging are likely to improve how cancer is understood at a systems level and, ultimately, should enable doctors not only to locate tumours but also to assess the activity of the biological processes within these tumours and to provide 'on the spot' treatment.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:41384304
Collections
- HMS Scholarly Articles [17714]
Contact administrator regarding this item (to report mistakes or request changes)